Clinical Trials Directory

Trials / Sponsors / Intergroupe Francophone du Myelome

Intergroupe Francophone du Myelome

Network · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Indu
Multiple Myeloma, Newly Diagnosed
Phase 32025-07-09
Active Not RecruitingAnalysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
Multiple Myeloma
—2023-09-19
Active Not RecruitingDiagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple
Multiple Myeloma
—2022-05-18
UnknownIsatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Bet
AL Amyloidosis
Phase 22022-02-11
Active Not RecruitingMInimal Residual Disease Adapted Strategy
Multiple Myeloma
Phase 32021-12-08
TerminatedAnalysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma
Multiple Myeloma, Covid19
N/A2020-12-16
Active Not RecruitingEvaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendat
Smoldering Multiple Myeloma
N/A2020-02-11
TerminatedIPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic
Multiple Myeloma, Relapsed and Refractory Multiple Myeloma, Genetic Condition
Phase 22019-11-03
CompletedA Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma
Multiple Myeloma
Phase 32015-09-01
CompletedAssessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
Multiple Myeloma, Blood Stem Cell Transplant Failure
—2015-06-01
CompletedStudy of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma
Multiple Myeloma
Phase 22010-03-03
CompletedPharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexame
Myeloma
N/A2009-07-29
UnknownStudy in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Tha
Multiple Myeloma
Phase 32008-03-01